ONC

insider transactions

BeOne Medicines Ltd. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-24.4K

0 buy · 24.4K sell

Net value · 365d

-$6.7M

$0 in · $6.7M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 24.4K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Sell·S
Jun 16, 26

Chan Henry Lee

SVP, General Counsel

$156.9K

590 sh · $265.98

Own -100%
Sell·S
Jun 16, 26

Lai Wang KEY

President, Global Head of R&D

$310.2K

1.2K sh · $265.39

Own -100%
Sell·S
Jun 16, 26

Xiaobin Wu KEY

President and COO

$362.0K

1.4K sh · $266.76

Own -100%
Sell·S
Jun 16, 26

John Oyler KEY

Chief Executive Officer

$88.8K

333 sh · $266.69

Own -100%
Sell·S
Jun 16, 26

John Oyler KEY

Chief Executive Officer

$454.8K

1.7K sh · $265.99

Own -84%
Sell·S
Jun 16, 26

John Oyler KEY

Chief Executive Officer

$437.0K

1.6K sh · $264.87

Own -45%
Grant·A
Jun 15, 26

Olivier Brandicourt

Director

$0

11.0K sh

Own New
Grant·A
Jun 15, 26

Olivier Brandicourt

Director

$0

2.2K sh

Own +88%
Grant·A
Jun 11, 26

Elizabeth Fisher Mooney

Director

$0

19.0K sh

Own New
Grant·A
Jun 11, 26

Charles Lazelle Sawyers

Director

$0

19.0K sh

Own +474500%
Grant·A
Jun 11, 26

Aaron Rosenberg KEY

Chief Financial Officer

$0

137.9K sh

Own New
Sell·S
Jun 11, 26

Aaron Rosenberg KEY

Chief Financial Officer

$162.6K

631 sh · $257.74

Own -100%
Grant·A
Jun 11, 26

Aaron Rosenberg KEY

Chief Financial Officer

$0

71.2K sh

Own +22%
Grant·A
Jun 11, 26

Chan Henry Lee

SVP, General Counsel

$0

87.3K sh

Own New
Sell·S
Jun 11, 26

Chan Henry Lee

SVP, General Counsel

$110.3K

428 sh · $257.64

Own -100%
Grant·A
Jun 11, 26

Chan Henry Lee

SVP, General Counsel

$0

45.1K sh

Own +15%
Grant·A
Jun 11, 26

Margaret Dugan

Director

$0

19.0K sh

Own +35%
Grant·A
Jun 11, 26

Alessandro Riva

Director

$0

19.0K sh

Own +35%
Grant·A
Jun 11, 26

Lai Wang KEY

President, Global Head of R&D

$0

229.8K sh

Own New
Sell·S
Jun 11, 26

Lai Wang KEY

President, Global Head of R&D

$197.3K

756 sh · $261.00

Own -100%
Grant·A
Jun 11, 26

Lai Wang KEY

President, Global Head of R&D

$0

118.6K sh

Own +7%
Grant·A
Jun 11, 26

Xiaobin Wu KEY

President and COO

$0

229.8K sh

Own New
Sell·S
Jun 11, 26

Xiaobin Wu KEY

President and COO

$163.5K

626 sh · $261.20

Own -100%
Grant·A
Jun 11, 26

Xiaobin Wu KEY

President and COO

$0

118.6K sh

Own +10%
Grant·A
Jun 11, 26

Xiaodong Wang

Director

$0

193.5K sh

Own New
Grant·A
Jun 11, 26

Xiaodong Wang

Director

$0

99.9K sh

Own +2%
Grant·A
Jun 11, 26

Shalini Sharp

Director

$0

19.0K sh

Own +99%
Grant·A
Jun 11, 26

Anthony C Hooper

Director

$0

19.0K sh

Own +29%
Grant·A
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$0

344.7K sh

Own New
Sell·S
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$38.6K

149 sh · $258.81

Own -100%
Sell·S
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$51.7K

200 sh · $258.28

Own -57%
Sell·S
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$221.3K

859 sh · $257.59

Own -71%
Sell·S
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$189.9K

741 sh · $256.23

Own -38%
Grant·A
Jun 11, 26

John Oyler KEY

Chief Executive Officer

$0

177.9K sh

Own +3%
Sell·S
Jun 11, 26

Titus B. Ball

Principal Accounting Officer

$30.9K

120 sh · $257.53

Own -100%
Sell·S
Jun 11, 26

Titus B. Ball

Principal Accounting Officer

$12.6K

49 sh · $256.39

Own -29%
Grant·A
Jun 11, 26

Titus B. Ball

Principal Accounting Officer

$0

31.2K sh

Own +46%
Grant·A
Jun 11, 26

Olivier Brandicourt

Director

$0

19.0K sh

Own +69%
Sell·S
Jun 8, 26

Chan Henry Lee

SVP, General Counsel

$43.4K

160 sh · $271.26

Own -100%
Sell·S
Jun 8, 26

Chan Henry Lee

SVP, General Counsel

$192.1K

711 sh · $270.24

Own -82%
Sell·S
Jun 8, 26

Lai Wang KEY

President, Global Head of R&D

$10.8K

40 sh · $270.73

Own -100%
Sell·S
Jun 8, 26

Lai Wang KEY

President, Global Head of R&D

$357.4K

1.3K sh · $269.34

Own -97%
Sell·S
Jun 8, 26

Xiaobin Wu KEY

President and COO

$10.8K

40 sh · $270.55

Own -100%
Sell·S
Jun 8, 26

Xiaobin Wu KEY

President and COO

$388.9K

1.4K sh · $269.33

Own -97%
Sell·S
Jun 8, 26

John Oyler KEY

Chief Executive Officer

$303.7K

1.1K sh · $271.14

Own -100%
Sell·S
Jun 8, 26

John Oyler KEY

Chief Executive Officer

$1.0M

3.8K sh · $270.38

Own -77%
Sell·S
Jun 8, 26

Titus B. Ball

Principal Accounting Officer

$9.8K

36 sh · $272.08

Own -100%
Sell·S
Jun 8, 26

Titus B. Ball

Principal Accounting Officer

$27.1K

100 sh · $271.06

Own -74%
Sell·S
Jun 1, 26

Qingqing Yi

Director

$65.6K

235 sh · $279.13

Own -100%
Sell·S
May 22, 26

Margaret Dugan

Director

$65.6K

212 sh · $309.60

Own -100%
Sell·S
May 22, 26

Alessandro Riva

Director

$65.6K

212 sh · $309.51

Own -100%
Sell·S
May 22, 26

Corazon (Corsee) D. Sanders

Director

$65.6K

212 sh · $309.59

Own -100%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.3K sh

Own +1%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.7K sh

Own +2%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.3K sh

Own +7%
Sell·S
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$103.2K

332 sh · $310.72

Own -100%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$15.6K

98 sh · $159.03

Own +42%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$28.4K

133 sh · $213.32

Own +132%
Exercise·M
May 13, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$19.6K

101 sh · $194.47

Own New
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.3K sh

Own +1%
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.7K sh

Own +2%
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.3K sh

Own +7%
Sell·S
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$103.4K

332 sh · $311.59

Own -100%
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$15.6K

98 sh · $159.03

Own +42%
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$28.4K

133 sh · $213.32

Own +132%
Exercise·M
Apr 8, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$19.6K

101 sh · $194.47

Own New
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.3K sh

Own +1%
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.7K sh

Own +2%
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

1.4K sh

Own +7%
Sell·S
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$102.3K

341 sh · $300.00

Own -100%
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$15.6K

98 sh · $159.03

Own +40%
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$28.4K

133 sh · $213.32

Own +121%
Exercise·M
Mar 11, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$21.4K

110 sh · $194.47

Own New
Grant·A
Mar 6, 26

Aaron Rosenberg KEY

Chief Financial Officer

$0

40.6K sh

Own +14%
Grant·A
Mar 6, 26

Aaron Rosenberg KEY

Chief Financial Officer

$0

79.0K sh

Own +37%
Grant·A
Mar 6, 26

Chan Henry Lee

SVP, General Counsel

$0

29.9K sh

Own +10%
Grant·A
Mar 6, 26

Chan Henry Lee

SVP, General Counsel

$0

65.4K sh

Own +29%
Grant·A
Mar 6, 26

Lai Wang KEY

President, Global Head of R&D

$0

55.0K sh

Own +4%
Grant·A
Mar 6, 26

Lai Wang KEY

President, Global Head of R&D

$0

112.6K sh

Own +8%
Grant·A
Mar 6, 26

Xiaobin Wu KEY

President and COO

$0

78.6K sh

Own +7%
Grant·A
Mar 6, 26

Xiaobin Wu KEY

President and COO

$0

168.9K sh

Own +17%
Grant·A
Mar 6, 26

John Oyler KEY

Chief Executive Officer

$0

117.9K sh

Own +2%
Grant·A
Mar 6, 26

John Oyler KEY

Chief Executive Officer

$0

327.0K sh

Own +6%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

6.4K sh

Own +6%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

8.6K sh

Own +11%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

6.5K sh

Own +38%
Sell·S
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$348.6K

996 sh · $350.00

Own -100%
Sell·S
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$231.6K

664 sh · $348.79

Own -40%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$78.9K

496 sh · $159.03

Own +43%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$141.2K

662 sh · $213.32

Own +132%
Exercise·M
Feb 4, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$97.6K

502 sh · $194.47

Own New
Grant·A
Jan 15, 26

Olivier Brandicourt

Director

$0

6.8K sh

Own New
Grant·A
Jan 15, 26

Olivier Brandicourt

Director

$0

1.4K sh

Own +118%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

2.5K sh

Own +2%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

3.5K sh

Own +4%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$0

2.6K sh

Own +9%
Sell·S
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$220.3K

664 sh · $331.76

Own -100%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$31.2K

196 sh · $159.03

Own +42%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$56.7K

266 sh · $213.32

Own +132%
Exercise·M
Jan 7, 26

Chan Henry Lee

SVP, General Counsel · 10b5-1

$39.3K

202 sh · $194.47

Own New
Grant·A
Dec 31, 25

Lai Wang KEY

President, Global Head of R&D

$0

427.9K sh

Own +42%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 16, 2026	Chan Henry Lee	SVP, General Counsel	Sell S	590	-100%	$265.98	$156.9K
Jun 16, 2026	Lai Wang KEY	President, Global Head of R&D	Sell S	1.2K	-100%	$265.39	$310.2K
Jun 16, 2026	Xiaobin Wu KEY	President and COO	Sell S	1.4K	-100%	$266.76	$362.0K
Jun 16, 2026	John Oyler KEY	Chief Executive Officer	Sell S	333	-100%	$266.69	$88.8K
Jun 16, 2026	John Oyler KEY	Chief Executive Officer	Sell S	1.7K	-84%	$265.99	$454.8K
Jun 16, 2026	John Oyler KEY	Chief Executive Officer	Sell S	1.6K	-45%	$264.87	$437.0K
Jun 15, 2026	Olivier Brandicourt	Director	Grant A	11.0K	New	—	$0
Jun 15, 2026	Olivier Brandicourt	Director	Grant A	2.2K	+88%	—	$0
Jun 11, 2026	Elizabeth Fisher Mooney	Director	Grant A	19.0K	New	—	$0
Jun 11, 2026	Charles Lazelle Sawyers	Director	Grant A	19.0K	+474500%	—	$0
Jun 11, 2026	Aaron Rosenberg KEY	Chief Financial Officer	Grant A	137.9K	New	—	$0
Jun 11, 2026	Aaron Rosenberg KEY	Chief Financial Officer	Sell S	631	-100%	$257.74	$162.6K
Jun 11, 2026	Aaron Rosenberg KEY	Chief Financial Officer	Grant A	71.2K	+22%	—	$0
Jun 11, 2026	Chan Henry Lee	SVP, General Counsel	Grant A	87.3K	New	—	$0
Jun 11, 2026	Chan Henry Lee	SVP, General Counsel	Sell S	428	-100%	$257.64	$110.3K
Jun 11, 2026	Chan Henry Lee	SVP, General Counsel	Grant A	45.1K	+15%	—	$0
Jun 11, 2026	Margaret Dugan	Director	Grant A	19.0K	+35%	—	$0
Jun 11, 2026	Alessandro Riva	Director	Grant A	19.0K	+35%	—	$0
Jun 11, 2026	Lai Wang KEY	President, Global Head of R&D	Grant A	229.8K	New	—	$0
Jun 11, 2026	Lai Wang KEY	President, Global Head of R&D	Sell S	756	-100%	$261.00	$197.3K
Jun 11, 2026	Lai Wang KEY	President, Global Head of R&D	Grant A	118.6K	+7%	—	$0
Jun 11, 2026	Xiaobin Wu KEY	President and COO	Grant A	229.8K	New	—	$0
Jun 11, 2026	Xiaobin Wu KEY	President and COO	Sell S	626	-100%	$261.20	$163.5K
Jun 11, 2026	Xiaobin Wu KEY	President and COO	Grant A	118.6K	+10%	—	$0
Jun 11, 2026	Xiaodong Wang	Director	Grant A	193.5K	New	—	$0
Jun 11, 2026	Xiaodong Wang	Director	Grant A	99.9K	+2%	—	$0
Jun 11, 2026	Shalini Sharp	Director	Grant A	19.0K	+99%	—	$0
Jun 11, 2026	Anthony C Hooper	Director	Grant A	19.0K	+29%	—	$0
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Grant A	344.7K	New	—	$0
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Sell S	149	-100%	$258.81	$38.6K
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Sell S	200	-57%	$258.28	$51.7K
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Sell S	859	-71%	$257.59	$221.3K
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Sell S	741	-38%	$256.23	$189.9K
Jun 11, 2026	John Oyler KEY	Chief Executive Officer	Grant A	177.9K	+3%	—	$0
Jun 11, 2026	Titus B. Ball	Principal Accounting Officer	Sell S	120	-100%	$257.53	$30.9K
Jun 11, 2026	Titus B. Ball	Principal Accounting Officer	Sell S	49	-29%	$256.39	$12.6K
Jun 11, 2026	Titus B. Ball	Principal Accounting Officer	Grant A	31.2K	+46%	—	$0
Jun 11, 2026	Olivier Brandicourt	Director	Grant A	19.0K	+69%	—	$0
Jun 8, 2026	Chan Henry Lee	SVP, General Counsel	Sell S	160	-100%	$271.26	$43.4K
Jun 8, 2026	Chan Henry Lee	SVP, General Counsel	Sell S	711	-82%	$270.24	$192.1K
Jun 8, 2026	Lai Wang KEY	President, Global Head of R&D	Sell S	40	-100%	$270.73	$10.8K
Jun 8, 2026	Lai Wang KEY	President, Global Head of R&D	Sell S	1.3K	-97%	$269.34	$357.4K
Jun 8, 2026	Xiaobin Wu KEY	President and COO	Sell S	40	-100%	$270.55	$10.8K
Jun 8, 2026	Xiaobin Wu KEY	President and COO	Sell S	1.4K	-97%	$269.33	$388.9K
Jun 8, 2026	John Oyler KEY	Chief Executive Officer	Sell S	1.1K	-100%	$271.14	$303.7K
Jun 8, 2026	John Oyler KEY	Chief Executive Officer	Sell S	3.8K	-77%	$270.38	$1.0M
Jun 8, 2026	Titus B. Ball	Principal Accounting Officer	Sell S	36	-100%	$272.08	$9.8K
Jun 8, 2026	Titus B. Ball	Principal Accounting Officer	Sell S	100	-74%	$271.06	$27.1K
Jun 1, 2026	Qingqing Yi	Director	Sell S	235	-100%	$279.13	$65.6K
May 22, 2026	Margaret Dugan	Director	Sell S	212	-100%	$309.60	$65.6K
May 22, 2026	Alessandro Riva	Director	Sell S	212	-100%	$309.51	$65.6K
May 22, 2026	Corazon (Corsee) D. Sanders	Director	Sell S	212	-100%	$309.59	$65.6K
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.3K	+1%	—	$0
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.7K	+2%	—	$0
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.3K	+7%	—	$0
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	332	-100%	$310.72	$103.2K
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	98	+42%	$159.03	$15.6K
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	133	+132%	$213.32	$28.4K
May 13, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	101	New	$194.47	$19.6K
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.3K	+1%	—	$0
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.7K	+2%	—	$0
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.3K	+7%	—	$0
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	332	-100%	$311.59	$103.4K
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	98	+42%	$159.03	$15.6K
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	133	+132%	$213.32	$28.4K
Apr 8, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	101	New	$194.47	$19.6K
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.3K	+1%	—	$0
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.7K	+2%	—	$0
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	1.4K	+7%	—	$0
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	341	-100%	$300.00	$102.3K
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	98	+40%	$159.03	$15.6K
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	133	+121%	$213.32	$28.4K
Mar 11, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	110	New	$194.47	$21.4K
Mar 6, 2026	Aaron Rosenberg KEY	Chief Financial Officer	Grant A	40.6K	+14%	—	$0
Mar 6, 2026	Aaron Rosenberg KEY	Chief Financial Officer	Grant A	79.0K	+37%	—	$0
Mar 6, 2026	Chan Henry Lee	SVP, General Counsel	Grant A	29.9K	+10%	—	$0
Mar 6, 2026	Chan Henry Lee	SVP, General Counsel	Grant A	65.4K	+29%	—	$0
Mar 6, 2026	Lai Wang KEY	President, Global Head of R&D	Grant A	55.0K	+4%	—	$0
Mar 6, 2026	Lai Wang KEY	President, Global Head of R&D	Grant A	112.6K	+8%	—	$0
Mar 6, 2026	Xiaobin Wu KEY	President and COO	Grant A	78.6K	+7%	—	$0
Mar 6, 2026	Xiaobin Wu KEY	President and COO	Grant A	168.9K	+17%	—	$0
Mar 6, 2026	John Oyler KEY	Chief Executive Officer	Grant A	117.9K	+2%	—	$0
Mar 6, 2026	John Oyler KEY	Chief Executive Officer	Grant A	327.0K	+6%	—	$0
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	6.4K	+6%	—	$0
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	8.6K	+11%	—	$0
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	6.5K	+38%	—	$0
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	996	-100%	$350.00	$348.6K
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	664	-40%	$348.79	$231.6K
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	496	+43%	$159.03	$78.9K
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	662	+132%	$213.32	$141.2K
Feb 4, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	502	New	$194.47	$97.6K
Jan 15, 2026	Olivier Brandicourt	Director	Grant A	6.8K	New	—	$0
Jan 15, 2026	Olivier Brandicourt	Director	Grant A	1.4K	+118%	—	$0
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	2.5K	+2%	—	$0
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	3.5K	+4%	—	$0
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	2.6K	+9%	—	$0
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Sell S	664	-100%	$331.76	$220.3K
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	196	+42%	$159.03	$31.2K
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	266	+132%	$213.32	$56.7K
Jan 7, 2026	Chan Henry Lee 10b5-1	SVP, General Counsel	Exercise M	202	New	$194.47	$39.3K
Dec 31, 2025	Lai Wang KEY	President, Global Head of R&D	Grant A	427.9K	+42%	—	$0

About ONC insider trading

This page tracks insider transactions for BeOne Medicines Ltd. (ONC) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.